A Straightforward Protocol for the Synthesis of Functionalized Tryptophan Peptides via Stille Coupling, Azidation and Photoinduced Nitrene Insertion

Lukas Junk; Uli Kazmaier

doi:10.1055/s-0035-1561410

Synlett, Table of Contents

Synlett 2016; 27(10): 1531-1536
DOI: 10.1055/s-0035-1561410

letter

A Straightforward Protocol for the Synthesis of Functionalized Tryptophan Peptides via Stille Coupling, Azidation and Photoinduced Nitrene Insertion

Lukas Junk

Institut für Organische Chemie, Universität des Saarlandes, 66123 Saarbrücken, Germany Email: u.kazmaier@mx.uni-saarland.de

,

Uli Kazmaier*

Institut für Organische Chemie, Universität des Saarlandes, 66123 Saarbrücken, Germany Email: u.kazmaier@mx.uni-saarland.de

› Author Affiliations

Abstract

All articles of this category

Abstract

Substituted and functionalized tryptophans are interesting building blocks in peptidic natural products. Stereoselective allylic alkylations of small peptides using stannylated allylic substrates allow the synthesis of stannylated peptides, which can be subjected to Stille couplings using (substituted) o-iodoanilines. Subsequent azidation and photochemical nitrene insertion allows the direct incorporation of modified tryptophans into peptides.

Key words

allylations - azides - nitrenes - peptides - Stille couplings - tryptophans

Full Text

References

References and Notes

1a Galliford CV, Scheidt KA. Angew. Chem. Int. Ed. 2007; 46: 8748
1b Bronner SM, Im GY. J, Garg NK. Heterocycles in Natural Product Synthesis . Majumdar KC, Chattopadhyay SK. Wiley-VCH; Weinheim: 2011: 221

2 Jakubczyk D, Cheng JZ, O’Connor SE. Nat. Prod. Rep. 2014; 31: 1328

3a Pedras MS, Yaya EE, Glawischnig E. Nat. Prod. Rep. 2011; 28: 1381
3b Xu W, Gavia DJ, Tang Y. Nat. Prod. Rep. 2014; 31: 1474

4 Fusetani N, Matsunaga S. Chem. Soc. Rev. 1963; 93: 1793

5a Kunze B, Jansen R, Sasse F, Höfle G, Reichenbach H. J. Antibiot. 1995; 48: 1262
5b Jansen R, Kunze B, Reichenbach H, Höfle G. Liebigs Ann. 1996; 285

6a Clark WD, Corbett T, Valeriote F, Crews P. J. Am. Chem. Soc. 1997; 119: 9285
6b Rubio BK, Robinson SJ, Avalos CE, Valeriote FA, de Voogd NJ, Crews P. J. Nat. Prod. 2008; 71: 1475
6c Garcia JM, Curzon SS, Watts KR, Konopelski JP. Org. Lett. 2012; 14: 2054

7 Plaza A, Keffer JL, Lloyd JR, Colin PL, Bewley CA. J. Nat. Prod. 2010; 73: 485

8a Phillips RS, Cohen LA. J. Am. Chem. Soc. 1986; 108: 2023
8b Miyake FY, Yakushijn K, Horne DA. Angew. Chem. Int. Ed. 2004; 43: 5357

9a Trzupek JD, Lee D, Crowley BM, Marathias VM, Danishefsky SJ. J. Am. Chem. Soc. 2010; 132: 8506
9b Jiang D, Xu Z, Jia Y. Tetrahedron 2012; 68: 4225
9c Xu M, Fan T.-Y, Zhang J.-X, Hao X.-J, Liu S. Chin. Chem. Lett. 2015; 26: 282

10a Ruiz-Rodriguez J, Albericio F, Lavilla R. Chem. Eur. J. 2010; 16: 1124
10b Preciado S, Mendive-Tapia L, Albericio F, Lavilla R. J. Org. Chem. 2013; 78: 8129
10c Potukuchi HK, Bach T. J. Org. Chem. 2013; 78: 12263
10d Williams TJ, Reay AJ, Whitwood AC, Fairlamb IJ. S. Chem. Commun. 2014; 50: 3052

11a Bittner S, Schwerzer R, Harlev E. Amino Acids 2007; 33: 19
11b Frese M, Guzowska PH, Voß H, Sewald N. ChemCatChem 2014; 6: 1270
11c Frese M, Sewald N. Angew. Chem. Int. Ed. 2015; 54: 298
11d Tanner ME. Nat. Prod. Rep. 2015; 32: 88

12 Liu Q, Li Q, Ma Y, Jia Y. Org. Lett. 2013; 15: 4528
13 Gribble GW. J. Chem. Soc., Perkin Trans. 1 2000; 1045

Selected recent reviews:

14a Krüger K, Tillack A, Beller M. Adv. Synth. Catal. 2008; 350: 2153
14b Barluenga J, Rodriguez F, Fananas J. Chem. Asian J. 2009; 4: 1036
14c Bandini M, Eichholzer A. Angew. Chem. Int. Ed. 2009; 48: 9608
14d Song JJ, Reeves JT, Fandrick DR, Tan Z, Yee NK, Senanayake CH. ARKIVOC 2010; (i): 390
14e Cacchi S, Fabrizi G, Goggiamani A. Org. Biomol. Chem. 2011; 9: 641

15a Ackermann L, Kaspar LT, Gschrei CJ. Chem. Commun. 2004; 2824
15b Ackermann L, Sandmann R, Villar A, Kaspar LT. Tetrahedron 2008; 64: 769
15c Gao D, Back TG. Chem. Eur. J. 2012; 18: 14828

16a Jia Y, Zhu J. J. Org. Chem. 2006; 71: 7826
16b Michaux J, Retailleau P, Campagne J.-M. Synlett 2008; 1532

17 Dacko CA, Akhmedov NG, Söderberg BC. G. Tetrahedron: Asymmetry 2008; 19: 2775

18a Mothes C, Lavielle S, Karoyan P. J. Org. Chem. 2008; 73: 6706
18b Tanaka M, Hikawa H, Yokoyama Y. Tetrahedron 2011; 67: 5897

19a Gander-Coquoz M, Seebach D. Helv. Chim. Acta 1988; 71: 224
19b Zhang L, Finn JM. J. Org. Chem. 1995; 60: 5719
19c Zhang P, Liu R, Cook JM. Tetrahedron Lett. 1995; 36: 9133
19d Gan T, Liu R, Yu P, Zhao S, Cook JM. J. Org. Chem. 1997; 62: 9298
19e Ma C, Liu X, Li X, Flippen-Anderson J, Yu S, Cook JM. J. Org. Chem. 2001; 66: 4525
19f Zhou H, Liao X, Cook JM. Org. Lett. 2004; 6: 249
19g Okada M, Sato I, Cho SJ, Suzuki Y, Ojika M, Dubnau D, Sakagami Y. Biosci., Biotechnol., Biochem. 2004; 68: 2374
19h Bittner S, Scherzer R, Harlev E. Amino Acids 2007; 33: 19
19i Edwankar CR, Edwankar RV, Namjoshi OA, Liao X, Cook JM. J. Org. Chem. 2013; 78: 6471

20a Schmidt U, Wild J. Liebigs Ann. Chem. 1985; 1882
20b Yokoyama Y, Matsumoto T, Murakami Y. J. Org. Chem. 1995; 60: 1486
20c Yokoyama Y, Hikawa H, Mitsuhashi M, Uyama A, Hiroki Y, Murakami Y. Eur. J. Org. Chem. 2004; 1244

21 Kazmaier U In Frontiers in Asymmetric Synthesis and Application of alpha-Amino Acids . Soloshonok VA, Izawa K. ACS Books; Washington: 2009: 157

22a Kazmaier U, Schneider C. Synlett 1996; 975
22b Krebs A, Kazmaier U. Tetrahedron Lett. 1996; 37: 7945
22c Kazmaier U, Schneider C. Tetrahedron Lett. 1998; 39: 817

23 Grandel R, Kazmaier U. Tetrahedron Lett. 1997; 38: 8009

24a Pohlman M, Kazmaier U. Org. Lett. 2003; 5: 2631
24b Pohlman M, Kazmaier U, Lindner T. J. Org. Chem. 2004; 69: 6909

25a Kazmaier U, Zumpe FL. Angew. Chem. Int. Ed. 1999; 38: 1468
25b Kazmaier U, Zumpe FL. Angew. Chem. Int. Ed. 2000; 39: 802
25c Kazmaier U, Lindner T. Angew. Chem. Int. Ed. 2005; 44: 3303
25d Kazmaier U, Stolz D. Angew. Chem. Int. Ed. 2006; 45: 3072
25e Kazmaier U, Stolz D, Krämer K, Zumpe F. Chem. Eur. J. 2008; 14: 1322

26a Kazmaier U, Schauß D, Raddatz S, Pohlman M. Chem. Eur. J. 2001; 7: 456
26b Bukovec C, Wesquet AO, Kazmaier U. Eur. J. Org. Chem. 2011; 1047

27a Krämer K, Deska J, Hebach C, Kazmaier U. Org. Biomol. Chem. 2009; 7: 103
27b Kazmaier U, Bayer A, Deska J. Synthesis 2013; 45: 1462

28a Kazmaier U, Deska J, Watzke A. Angew. Chem. Int. Ed. 2006; 45: 4855
28b Datta S, Kazmaier U. Org. Biomol. Chem. 2011; 9: 872
28c Datta S, Bayer A, Kazmaier U. Org. Biomol. Chem. 2012; 10: 8268

29a Deska J, Kazmaier U. Angew. Chem. Int. Ed. 2007; 46: 4570
29b Deska J, Kazmaier U. Chem. Eur. J. 2007; 13: 6204

30 Kazmaier U, Schauß D, Pohlman M, Raddatz S. Synthesis 2000; 914

31a Mee SP. H, Lee V, Baldwin JE. Angew. Chem. Int. Ed. 2004; 43: 1132
31b Mee SP. H, Lee V, Baldwin JE. Chem. Eur. J. 2005; 11: 3294

32a Crisp GT, Glink PT. Tetrahedron Lett. 1992; 33: 4649
32b Crisp GT, Glink PT. Tetrahedron Lett. 1994; 50: 3213

33 Han X, Stoltz BM, Corey EJ. J. Am. Chem. Soc. 1999; 121: 7600
34 Stille Couplings; General Procedure 1: An oven-dried Schlenk tube was charged with LiCl (2.0 equiv) and heated with a heat gun under vacuum (< 0.1 mbar). After cooling to room temperature, CuI (2.0 equiv), (substituted) o-iodoaniline (1.0 equiv) and Pd(PPh₃)₄ (5 mol%) were added and the flask was evacuated and refilled with Ar three times. DMF (10 mL/mmol), which was previously degassed by bubbling with Ar, and the organotin compound (1.2 equiv) were added and the mixture was heated to 80 °C for 18 h. Upon reaching full conversion (TLC analysis), the mixture was diluted with EtOAc and 1 M KF solution (5 mL/mmol) was added. Upon vigorous shaking (in the Schlenk tube) a colourless precipitate formed and the mixture was filtered through a pad of Celite with EtOAc. The layers were separated and the aqueous layer was extracted twice with EtOAc. The combined organic layers were dried over Na₂SO₄, filtered and concentrated. The residue was purified by (automated) flash chromatography. tert-Butyl N-Trifluoroacetyl-2-amino-4-(2-amino-5-ethoxycarbonylphenyl)pent-4-enoate (3c): According to General Procedure 1, 3-iodobenzocaine (73 mg, 0.250 mmol) was reacted with 1 (176 mg, 0.300 mmol, 96% purity), LiCl (21 mg, 0.500 mmol), CuI (95 mg, 0.500 mmol) and Pd(PPh₃)₄ (14 mg, 12.5 µmol). Flash chromatography (PE–EtOAc, 80:20) afforded aniline 3c (71 mg, 0.164 mmol, 66%) as a brown solid; mp 151–152 °C; R_f = 0.34 (PE–EtOAc, 70:30). ¹H NMR (400 MHz, CDCl₃): δ = 1.36 (t, J = 7.1 Hz, 3 H), 1.43 (s, 9 H), 2.93 (dd, J = 14.3, 5.3 Hz, 1 H), 3.12 (ddd, J = 14.3, 5.4, 0.7 Hz, 1 H), 4.25 (br s, 2 H), 4.32 (q, J = 7.1 Hz, 2 H), 4.56 (m, 1 H), 5.27 (d, J = 1.5 Hz, 1 H), 5.40 (m, 1 H), 6.68 (d, J = 8.4 Hz, 1 H), 7.06 (d, J = 7.29 Hz, 1 H), 7.69 (d, J = 2.0 Hz, 1 H), 7.77 (dd, J = 8.4, 2.0 Hz, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 14.4, 27.9, 39.0, 52.5, 60.4, 83.6, 115.1, 120.2, 120.4, 125.7, 130.5, 130.6, 141.1, 147.3, 166.4, 169.0 ppm. Signals of the TFA group could not be observed. HRMS (CI): m/z [M]⁺ calcd for C₂₀H₂₅F₃N₂O₅: 430.1710; found: 430.1674. tert-Butyl N-Trifluoroacetyl-(S)-phenylalanyl-(R)-2-amino-4-(2-aminophenyl)pent-4-enoate (6c): According to General Procedure 1, 2-iodoaniline (42 mg, 0.191 mmol) was reacted with 5b (156 mg, 0.222 mmol), LiCl (16 mg, 0.370 mmol), CuI (71 mg, 0.370 mmol) and Pd(PPh₃)₄ (11 mg, 9 µmol). Column chromatography (PE–EtOAc, 70:30) afforded aniline 6c (83 mg, 0.170 mmol, 86%) as a brown solid; mp 57–59 °C; R_f = 0.24 (PE–EtOAc, 70:30); [α]_D ²⁰ = –23.0 (c 1.3, CHCl₃). ¹H NMR (400 MHz, CDCl₃): δ = 1.42 (s, 9 H), 2.73–2.92 (m, 4 H, 4-H), 3.83 (br s, 2 H), 4.46–4.54 (m, 2 H), 5.15 (d, J = 1.8 Hz, 1 H), 5.26 (m, 1 H), 6.68 (d, J = 8.3 Hz, 1 H), 6.71 (dd, J = 8.0, 1.0 Hz, 1 H), 6.76 (ddd, J = 7.5, 7.5, 1.1 Hz, 1 H), 6.96 (dd, J = 7.6, 1.5 Hz, 1 H), 7.02–7.09 (m, 4 H), 7.23–7.29 (m, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 28.0, 37.8, 39.4, 52.5, 54.3, 82.6, 116.3, 119.0, 119.4, 127.3, 127.9, 128.6, 128.7, 128.7, 129.3, 135.2, 142.3, 142.6, 156.5 (² J _F = 37.5 Hz), 168.4, 169.7. The signal of the CF₃ group could not be observed. HRMS (CI): m/z [M + H]⁺ calcd for C₂₆H₃₁F₃N₃O₄: 506.2261; found: 506.2263.
35 Diazotation/Azidation of Anilines; General Procedure 2: The aniline derivative was dissolved in a mixture of MeCN and 0.5 M HCl (1:1, 0.05 M). Subsequently, NaNO₂ (1.6 equiv) was added at 0 °C. After stirring for 5 min, NaN₃ (1.6 equiv) was added. After stirring for 5 min, sat. NaHCO₃ solution was added and the aqueous phase was extracted three times with CH₂Cl₂. The organic layer was dried over Na₂SO₄, concentrated, and the residue was purified by (automated) flash chromatography. tert-Butyl N-Trifluoroacetyl-2-amino-4-(2-azido-5-ethoxycarbonylphenyl)pent-4-enoate (2c): According to General Procedure 2, 3c (55 mg, 0.128 mmol) was reacted with NaNO₂ (14 mg, 0.204 mmol) and NaN₃ (13.3 mg, 0.204 mmol). Automated flash chromatography (PE–EtOAc, 100:0 to 90:10) afforded azide 2c (46 mg, 0.101 mmol, 79%) as a colourless resin; R_f = 0.19 (PE–EtOAc, 90:10). ¹H NMR (400 MHz, CDCl₃): δ = 1.39 (t, J = 7.1 Hz, 3 H), 1.40 (s, 9 H), 2.99 (dd, J = 14.6, 6.0 Hz, 1 H), 3.21 (dd, J = 14.6, 5.8 Hz, 1 H), 4.37 (q, J = 7.1 Hz, 2 H), 4.44 (m, 1 H), 5.19 (d, J = 0.9 Hz, 1 H), 5.31 (d, J = 0.9 Hz, 1 H), 6.84 (d, J = 7.1 Hz, 1 H), 7.18 (d, J = 8.4 Hz, 1 H), 7.83 (d, J = 2.0 Hz, 1 H), 8.01 (dd, J = 8.4, 2.0 Hz, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 14.3, 27.8, 38.1, 52.1, 61.2, 83.4, 118.2, 121.2, 127.1, 130.5, 131.8, 132.6, 141.0, 141.7, 165.5, 169.0. Signals of the TFA group could not be observed. HRMS (CI): m/z [M – N₂]⁺ calcd for C₂₀H₂₃F₃N₂O₅: 428.1554; found: 428.1544. tert-Butyl N-Trifluoroacetyl-(S)-phenylalanyl-(R)-2-amino-4-(2-azidophenyl)pent-4-enoate (7c): According to General Procedure 2, 6c (64 mg, 0.123 mmol) was reacted with NaNO₂ (14 mg, 0.196 mmol) and NaN₃ (13 mg, 0.196 mmol). Column chromatography (PE–EtOAc, 80:20) gave azide 7c (59 mg, 0.111 mmol, 90%) as a colourless resin; R_f = 0.31 (PE–EtOAc, 80:20). ¹H NMR (400 MHz, CDCl₃): δ = 1.36 (s, 9 H), 2.87 (m, 2 H), 2.99 (d, J = 6.8 Hz, 2 H), 4.36 (m, 1 H), 4.57 (m, 1 H), 5.06 (m, 1 H), 5.10 (m, 1 H), 6.01 (d, J = 7.2 Hz, 1 H), 7.06–7.17 (m, 6 H), 7.27–7.35 (m, 4 H). ¹³C NMR (100 MHz, CDCl₃): δ = 27.9, 38.3, 38.8, 52.0, 54.5, 82.6, 118.4, 119.9, 125.0, 127.5, 128.8, 129.2, 129.2, 130.6, 133.1, 135.1, 137.1, 142.3, 168.4, 169.9. Signals of the TFA group could not be observed. HRMS (CI): m/z [M – N₂]⁺ calcd for C₂₆H₂₈F₃N₃O₄: 503.2026; found: 503.2034.

36a Shen M, Leslie BE, Driver TG. Angew. Chem. Int. Ed. 2008; 47: 5056
36b Stokes BJ, Richert KJ, Driver TG. J. Org. Chem. 2009; 74: 6442
36c Sun K, Liu S, Bec PM, Driver TG. Angew. Chem. Int. Ed. 2011; 50: 1702

37 Farney EP, Yoon TP. Angew. Chem. Int. Ed. 2014; 53: 793

For photochemical indole syntheses using aryl azides, see:

38a Smith PA. S, Brown BB. J. Am. Chem. Soc. 1952; 73: 2435
38b Sundberg RJ, Russell HF, Ligon WV. Jr, Lin L.-S. J. Org. Chem. 1972; 37: 719
38c Molina P, Alcantara J, Lopez-Leonardo C. Tetrahedron Lett. 1995; 36: 953
38d Leogane O, Lebel H. Angew. Chem. Int. Ed. 2008; 47: 350
38e Bobeck DR, France S, Leverett CA, Sánchez-Cantalejo F, Padwa A. Tetrahedron Lett. 2009; 50: 3145
38f Xia XD, Xuan J, Wang Q, Lu L.-Q, Chen JR, Xiao WJ. Adv. Synth. Catal. 2014; 356: 2807

39 UV-LED Smart from Opsytec Dr. Gröbel GmbH (λ = 365 nm, max. irradiance >25 W·cm^–2, beam profile: standard).
40 Photocyclization of Azides; General Procedure 3: The azide was dissolved in MeCN (10 mL/mmol) in a round-bottom flask, which was then wrapped with aluminium foil and irradiated with an UV-LED lamp at 25% (6.25 W·cm^–2) of the maximum irradiance for the specified time at room temperature under laboratory atmosphere (Figure 1). The solvent was removed by evaporation and the residue was purified by (automated) flash chromatography. tert-Butyl N-Trifluoroacetyl-(5-ethoxycarbonyl)tryptophanate (4c): According to General Procedure 3, azide 2c (45 mg, 98.6 µmol) was irradiated for 13 h. Automated flash chromatography (PE–EtOAc, 100:0 to 80:20) afforded indole 4c (30 mg, 70.0 μmol, 71%) as a colourless solid; mp 119–120 °C; R_f = 0.14 (PE–EtOAc, 80:20). ¹H NMR (400 MHz, CDCl₃): δ = 1.40 (s, 9 H), 1.41 (t, J = 7.1 Hz, 3 H), 3.41 (m, 2 H), 4.40 (q, J = 7.1 Hz, 2 H), 4.82 (m, 1 H), 6.96 (d, J = 7.1 Hz, 1 H), 7.07 (d, J = 2.2 Hz, 1 H), 7.36 (d, J = 8.6 Hz, 1 H), 7.93 (dd, J = 8.6, 1.4 Hz, 1 H), 8.34 (s, 1 H), 8.47 (br s, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 14.4, 26.7, 27.8, 53.7, 60.7, 83.7, 110.8, 111.0, 121.5, 122.2, 123.9, 124.1, 127.1, 138.5, 167.5, 169.2. Signals of the TFA group could not be observed. HRMS (CI): m/z [M]⁺ calcd for C₂₀H₂₃F₃N₂O₅: 428.1554; found: 428.1569. tert-Butyl N-Trifluoroacetyl-(S)-phenylanalyl-(R)-tryptophanate (8c): According to General Procedure 3, azide 7c (42 mg, 79.0 μmol) was irradiated for 11.5 h. Column chromatography (PE–EtOAc, 70:30) gave dipeptide 8c (33 mg, 65.5 μmol, 83%) as a colourless solid; mp 178–179 °C. Diastereomeric ratio: (S,R)-8c/(S,S)-8c = 96:4; R_f = 0.26 (PE–EtOAc, 70:30). [α]_D ²⁰ = +26.3 (c 1.0, DMF). ¹H NMR (400 MHz, CD₃OD): δ = 1.37 (s, 9 H), 2.78 (dd, J = 13.8, 8.8 Hz, 1 H), 2.95 (dd, J = 13.8, 5.9 Hz, 1 H), 3.04 (dd, J = 14.6, 8.5 Hz, 1 H), 3.22 (dd, J = 14.6, 5.9 Hz, 1 H), 4.60 (m, 1 H), 4.71 (m, 1 H), 7.00–7.05 (m, 3 H), 7.10 (m, 1 H), 7.14–7.16 (m, 3 H), 7.33 (d, J = 8.0 Hz, 1 H), 7.54 (d, J = 7.8 Hz, 1 H). Signals of N-H protons could not be observed. ¹³C NMR (100 MHz, CD₃OD): δ = 28.1, 28.5, 38.6, 55.5, 56.0, 82.9, 110.8, 112.3, 119.3, 119.8, 122.5, 124.5, 127.9, 128.7, 129.4, 130.2, 137.5, 138.1, 171.7, 172.4. Signals of the TFA group could not be observed. HPLC (Repropsil 100 Chiral-NR 8 μm (250 × 4.6 mm), hexane–i-PrOH, 90:10 (5 min), 90:10 to 70:30 (10 min), 70:30 (15 min); 1 mL/min): t_R = 11.20 [(S,S)-8c], 12.76 [(S,R)-8c] min. HRMS (CI): m/z [M + H]⁺ calcd for C₂₆H₂₉F₃N₃O₄: 504.2105; found: 504.2096.

41a Shuttleworth SJ, Lizarzaburu ME, Chai A, Coward P. Bioorg. Med. Chem. Lett. 2004; 4: 3037
41b Farmanzadeh D, Najafi M. Bull. Chem. Soc. Jpn. 2013; 86: 1041

Supplementary Material

Supporting Information